What is CCEL's earnings growth forecast for 2026-2026?
(NYSEMKT: CCEL) Cryo Cell International's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Cryo Cell International's earnings in 2026 is -$473,567.
In 2026, CCEL is forecast to generate -$3,450,826 in earnings, with the lowest earnings forecast at -$3,315,500 and the highest earnings forecast at -$3,552,321.
What is CCEL's revenue growth forecast for 2026-2026?
(NYSEMKT: CCEL) Cryo Cell International's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Cryo Cell International's revenue in 2026 is $31,747,500.
In 2026, CCEL is forecast to generate $245,859,288 in revenue, with the lowest revenue forecast at $236,225,329 and the highest revenue forecast at $253,092,813.
What is CCEL's forecast return on assets (ROA) for 2026-2026?
(NYSEMKT: CCEL) forecast ROA is -5.46%, which is lower than the forecast US Medical Care Facilities industry average of 8.84%.
What is CCEL's Earnings Per Share (EPS) forecast for 2026-2026?
(NYSEMKT: CCEL) Cryo Cell International's current Earnings Per Share (EPS) is -$0.07. In 2026, CCEL's EPS is forecast to hit -$0.43 (min: -$0.41, max: -$0.44).
What is CCEL's forecast return on equity (ROE) for 2026-2026?
(NYSEMKT: CCEL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.